Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP951269.RASjqTo7IU0MzRwq68tBl1LrPhHcnUrCrO8NO_age5qfs130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP951269.RASjqTo7IU0MzRwq68tBl1LrPhHcnUrCrO8NO_age5qfs130_assertion type Assertion NP951269.RASjqTo7IU0MzRwq68tBl1LrPhHcnUrCrO8NO_age5qfs130_head.
- NP951269.RASjqTo7IU0MzRwq68tBl1LrPhHcnUrCrO8NO_age5qfs130_assertion description "[A stratified analysis by menopausal status indicated the association between the NAT2 SNP (rs1799930) and breast cancer was mainly evident in premenopausal women (OR 2.70, 95% CI 1.20-6.07), while the MTRR SNP (rs162049) was significant in postmenopausal women (OR 1.61, 95% CI 1.07-2.44).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP951269.RASjqTo7IU0MzRwq68tBl1LrPhHcnUrCrO8NO_age5qfs130_provenance.
- NP951269.RASjqTo7IU0MzRwq68tBl1LrPhHcnUrCrO8NO_age5qfs130_assertion evidence source_evidence_literature NP951269.RASjqTo7IU0MzRwq68tBl1LrPhHcnUrCrO8NO_age5qfs130_provenance.
- NP951269.RASjqTo7IU0MzRwq68tBl1LrPhHcnUrCrO8NO_age5qfs130_assertion SIO_000772 20180013 NP951269.RASjqTo7IU0MzRwq68tBl1LrPhHcnUrCrO8NO_age5qfs130_provenance.
- NP951269.RASjqTo7IU0MzRwq68tBl1LrPhHcnUrCrO8NO_age5qfs130_assertion wasDerivedFrom befree-20150227 NP951269.RASjqTo7IU0MzRwq68tBl1LrPhHcnUrCrO8NO_age5qfs130_provenance.
- NP951269.RASjqTo7IU0MzRwq68tBl1LrPhHcnUrCrO8NO_age5qfs130_assertion wasGeneratedBy ECO_0000203 NP951269.RASjqTo7IU0MzRwq68tBl1LrPhHcnUrCrO8NO_age5qfs130_provenance.